These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 9774108

  • 1. Efficiency of signalling through cytokine receptors depends critically on receptor orientation.
    Syed RS, Reid SW, Li C, Cheetham JC, Aoki KH, Liu B, Zhan H, Osslund TD, Chirino AJ, Zhang J, Finer-Moore J, Elliott S, Sitney K, Katz BA, Matthews DJ, Wendoloski JJ, Egrie J, Stroud RM.
    Nature; 1998 Oct 01; 395(6701):511-6. PubMed ID: 9774108
    [Abstract] [Full Text] [Related]

  • 2. The influence of domain structures on the signal transduction of chimeric receptors derived from the erythropoietin receptor.
    Liu W, Kawahara M, Ueda H, Nagamune T.
    J Biochem; 2009 May 01; 145(5):575-84. PubMed ID: 19155265
    [Abstract] [Full Text] [Related]

  • 3. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A, Arai K.
    Oncologist; 1996 May 01; 1(5):337-339. PubMed ID: 10388012
    [Abstract] [Full Text] [Related]

  • 4. Refolding, purification, and characterization of human erythropoietin binding protein produced in Escherichia coli.
    Johnson DL, Middleton SA, McMahon F, Barbone FP, Kroon D, Tsao E, Lee WH, Mulcahy LS, Jolliffe LK.
    Protein Expr Purif; 1996 Feb 01; 7(1):104-13. PubMed ID: 9172774
    [Abstract] [Full Text] [Related]

  • 5. Molecular recognition events involved in the activation of the growth hormone receptor by growth hormone.
    Behncken SN, Waters MJ.
    J Mol Recognit; 1999 Feb 01; 12(6):355-62. PubMed ID: 10611645
    [Abstract] [Full Text] [Related]

  • 6. Mimicry of erythropoietin and interleukin-6 signalling by an antibody/cytokine receptor chimera in murine myeloid 32D cells.
    Kawahara M, Ueda H, Tsumoto K, Kumagai I, Nagamune T.
    J Biochem; 2007 Apr 01; 141(4):563-71. PubMed ID: 17442704
    [Abstract] [Full Text] [Related]

  • 7. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation.
    Livnah O, Johnson DL, Stura EA, Farrell FX, Barbone FP, You Y, Liu KD, Goldsmith MA, He W, Krause CD, Pestka S, Jolliffe LK, Wilson IA.
    Nat Struct Biol; 1998 Nov 01; 5(11):993-1004. PubMed ID: 9808045
    [Abstract] [Full Text] [Related]

  • 8. Crystal structures of alpha-helical cytokine-receptor complexes: we've only scratched the surface.
    Walter MR.
    Biotechniques; 2002 Oct 01; Suppl():46-8, 50-7. PubMed ID: 12395927
    [Abstract] [Full Text] [Related]

  • 9. Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction.
    Philo JS, Aoki KH, Arakawa T, Narhi LO, Wen J.
    Biochemistry; 1996 Feb 06; 35(5):1681-91. PubMed ID: 8634300
    [Abstract] [Full Text] [Related]

  • 10. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
    Um M, Gross AW, Lodish HF.
    Cell Signal; 2007 Mar 06; 19(3):634-45. PubMed ID: 17045782
    [Abstract] [Full Text] [Related]

  • 11. Ligand binding kinetics of a soluble full-length murine erythropoietin receptor.
    Avedissian LS, Poola I, Spivak JL.
    Biochem Biophys Res Commun; 1995 Nov 02; 216(1):62-8. PubMed ID: 7488125
    [Abstract] [Full Text] [Related]

  • 12. Covering a broad dynamic range: information processing at the erythropoietin receptor.
    Becker V, Schilling M, Bachmann J, Baumann U, Raue A, Maiwald T, Timmer J, Klingmüller U.
    Science; 2010 Jun 11; 328(5984):1404-8. PubMed ID: 20488988
    [Abstract] [Full Text] [Related]

  • 13. NMR structure of human erythropoietin and a comparison with its receptor bound conformation.
    Cheetham JC, Smith DM, Aoki KH, Stevenson JL, Hoeffel TJ, Syed RS, Egrie J, Harvey TS.
    Nat Struct Biol; 1998 Oct 11; 5(10):861-6. PubMed ID: 9783743
    [Abstract] [Full Text] [Related]

  • 14. Erythropoietin cell biology.
    Sawyer ST, Penta K.
    Hematol Oncol Clin North Am; 1994 Oct 11; 8(5):895-911. PubMed ID: 7852213
    [Abstract] [Full Text] [Related]

  • 15. Analysis of the Asymmetry of Activated EPO Receptor Enables Designing Small Molecule Agonists.
    Guarnieri F.
    Vitam Horm; 2017 Oct 11; 105():19-37. PubMed ID: 28629518
    [Abstract] [Full Text] [Related]

  • 16. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O, Fusil F, Henri A, Villette JM, Leboulch P, Beuzard Y, Payen E.
    Exp Hematol; 2008 Apr 11; 36(4):412-23. PubMed ID: 18295963
    [Abstract] [Full Text] [Related]

  • 17. A high-throughput assay to identify compounds that can induce dimerization of the erythropoietin receptor.
    Biazzo DE, Motamedi H, Mark DF, Qureshi SA.
    Anal Biochem; 2000 Feb 01; 278(1):39-45. PubMed ID: 10640351
    [Abstract] [Full Text] [Related]

  • 18. A diversity of antibody epitopes can induce signaling through the erythropoietin receptor.
    Lim AC, Ketchem RR, Borges L, Carabeo T, Carter J, Hoover JE, Hu Z, Wittekind M, Zhou H, Mehlin C.
    Biochemistry; 2010 May 11; 49(18):3797-804. PubMed ID: 20337434
    [Abstract] [Full Text] [Related]

  • 19. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor.
    Wiesmann C, Ultsch MH, Bass SH, de Vos AM.
    Nature; 1999 Sep 09; 401(6749):184-8. PubMed ID: 10490030
    [Abstract] [Full Text] [Related]

  • 20. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation.
    Livnah O, Stura EA, Middleton SA, Johnson DL, Jolliffe LK, Wilson IA.
    Science; 1999 Feb 12; 283(5404):987-90. PubMed ID: 9974392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.